U.S. Personal Products Stock News

In early February 2026, Howard Hughes Holdings Inc. completed two US$500,000,000 fixed-rate senior unsecured note offerings, issuing 5.875% notes due 2032 and 6.125% notes due 2034 under Regulation S and Rule 144A. These bond deals coincided with a shareholder lawsuit challenging Pershing Square’s control arrangements at Howard Hughes, sharpening investor focus on governance, capital structure, and minority shareholder protections. We’ll now examine how the shareholder lawsuit over Pershing...

In February 2026, White Mountains Insurance Group reported past fourth-quarter 2025 revenue of US$1,603.8 million and net income of US$835.8 million, reversing a loss in the prior-year period and lifting earnings per share from a loss to US$327.23. For full-year 2025, the company’s revenue rose to US$3.74 billion and net income to US$1.11 billion, while it also completed a long-running share repurchase program that retired 8.02% of its shares since 2016. Against this backdrop, we’ll examine...

NGL Energy Partners LP recently reported past third-quarter fiscal 2025 results showing higher net income and a shift to earnings per share profitability despite lower revenue, while also completing a share repurchase of 8,401,351 units for US$46.72 million. Shortly after, the partnership filed a US$121.3 million shelf registration for 10,000,000 common units under an ESOP-related offering, signaling an effort to balance employee ownership incentives with expanded capital flexibility. We...

In February 2026, LuxExperience B.V. reported second-quarter sales of €646.92 million and a net loss of €12.64 million, while also updating full-year 2026 guidance to target GMV between €2.5 billion and €2.7 billion under its ongoing transformation plan. The combination of strong year-on-year sales growth and tighter guidance ranges highlights management’s confidence in executing its operational overhaul despite continued losses. With LuxExperience tightening full-year GMV guidance, we’ll...

Illinois Tool Works Inc. recently reported fourth-quarter 2025 results showing higher sales of US$4,093 million and net income of US$790 million year-on-year, while also detailing full-year 2025 performance and share repurchases totaling US$3.01 billions since August 2023. In addition, the company declared a first-quarter 2026 dividend of US$1.61 per share, equivalent to US$6.44 on an annualized basis, underscoring its continued emphasis on returning cash to shareholders through both...

If you are looking at Louisiana-Pacific and asking whether the current share price lines up with the underlying business, you are in the right place. The stock closed at US$93.62, with a 5.0% decline over the last 7 days, a 0.5% return over 30 days, a 14.5% return year to date, and returns of a 15.7% decline over 1 year, 50.3% over 3 years, and 110.4% over 5 years. These mixed returns hint that the market has been reassessing both the potential and the risks around Louisiana-Pacific. To...

In early February 2026, Atmos Energy shareholders approved extensive amendments to the company’s charters and bylaws, including lifting authorized common shares to 400 million and updating rules on director elections, officer liability, indemnification, meeting procedures, and legal forums. These governance changes, together with the board’s alignment on modernized bylaws, give Atmos Energy greater flexibility for future capital raising and corporate actions while tightening legal and...

If you are wondering whether DRDGOLD's share price still reflects fair value after its recent run, this article walks through the key valuation checks to help you frame that question clearly. The stock last closed at US$35.65, with a 1.6% return over 7 days, a 1.6% decline over 30 days and returns of 17.6% year to date, 251.3% over 1 year, 412.2% over 3 years and 327.9% over 5 years. Recent coverage has focused on DRDGOLD's share price performance and how investors are reacting to changes in...

If you are wondering whether Greif is still reasonably priced after its recent run, you are not alone. This article will focus squarely on what you might be paying for each dollar of the business. The stock last closed at US$76.82, with returns of 3.5% over 7 days, 6.8% over 30 days, 12.2% year to date, 30.2% over 1 year, 18.4% over 3 years and 90.6% over 5 years. This naturally raises questions about how much value is already reflected in the price. Recent coverage of Greif has highlighted...

If you are wondering whether Radian Group at around US$32.82 is offering good value or not, this article is going to focus squarely on what the current price might mean for long term investors. The stock is roughly flat over the last 7 days at 0.2%, slightly lower over the past month with a 0.9% decline, and shows longer term returns of 3.2% over 1 year, 60.7% over 3 years, and 88.6% over 5 years. Recent coverage around Radian Group has mainly centered on its position in the US mortgage...

Two Harbors Investment Corp. recently reported fourth-quarter 2025 results, with net income falling to US$11.72 million and a basic loss per share from continuing operations of US$0.02, compared with basic earnings per share of US$2.54 a year earlier. For the full year 2025, the company moved from net income of US$298.17 million to a net loss of US$454.30 million, underscoring a sharp swing in profitability that reframes how investors may view its risk and return profile. Against this...

Galecto, Inc. recently completed a follow-on public offering of common stock, issuing 16,644,737 shares and raising approximately US$316.3 million before fees, with Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities acting as joint book-running managers. Alongside this offering, Galecto filed a mixed shelf registration of up to US$150 million, giving the company additional flexibility to issue various securities over time to support its pipeline in blood cancers and fibrotic...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The nCino, Inc. ( NASDAQ:NCNO ) share price has fared very poorly over the last month, falling by a substantial 33...

Allegion plc's ( NYSE:ALLE ) periodic dividend will be increasing on the 31st of March to $0.55, with investors...

Apollo Global Management, Inc. ( NYSE:APO ) is about to trade ex-dividend in the next 2 days. The ex-dividend date is...

Wondering whether Alvotech at US$4.64 is a potential bargain or a value trap? This article will walk you through what the current price might be implying about the company. The stock has had a tough run, with a 9.7% decline over the last week, 5.7% over the last month and 7.2% year to date, while the 1 year return sits at a 64.3% loss. Recent trading has been shaped by ongoing investor reaction to Alvotech's progress and risks in the biosimilars space, as the market weighs its prospects...

If you are wondering whether UiPath is starting to look interesting at current levels, this article will walk through what the recent share price and fundamentals might be telling you about its value. UiPath shares last closed at US$11.32, with returns of 12.9% decline over 7 days, 21.1% decline over 30 days, 28.7% decline year to date, 24.2% decline over 1 year and 27.2% decline over 3 years, which may have shifted how the market is thinking about its risk and potential. Recent headlines...

Why ADT’s index additions matter for investors ADT (ADT) has just been added to the S&P 600, S&P 1000, S&P Composite 1500, and the S&P 600 Consumer Discretionary index, a shift that can influence trading interest and liquidity. See our latest analysis for ADT. ADT’s recent index additions come after a period where short term share price returns have been soft, with a 7 day share price return decline of 4.56% and a 30 day share price return decline of 6.18%. Meanwhile, the 1 year total...

Immunic, Inc. recently secured an oversubscribed private placement of up to US$400.01 million and outlined plans to complete phase 3 trials and pursue regulatory approval for its multiple sclerosis candidate vidofludimus calcium, while also initiating a CEO search and refreshing its board to support an eventual commercial launch. A distinctive aspect of this update is Immunic’s simultaneous push into both relapsing and primary progressive multiple sclerosis, coupled with bringing in...

Event context and recent share performance SPS Commerce (SPSC) has drawn investor attention after a stretch of weaker share performance, with the stock down about 4% over the past week and 31% over the past month. That short term pressure sits alongside a 58% decline over the past year and a 59% total return drop over the past 3 months, prompting closer scrutiny of the company’s fundamentals and valuation. See our latest analysis for SPS Commerce. At a share price of US$61.92, SPS Commerce’s...

As February begins, the U.S. stock market has shown significant strength, with major indexes like the Dow Jones Industrial Average and S&P 500 posting notable gains. This positive momentum in the market presents a timely opportunity to explore stocks that might be trading below their estimated fair value. Identifying undervalued stocks requires careful analysis of both market conditions and individual company fundamentals, offering potential for investors seeking value in a robust financial...

As February begins, major U.S. stock indexes have shown strength, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing a record high. In this robust market environment, companies with strong insider ownership and impressive revenue growth can be particularly appealing to investors looking for potential opportunities in the growth sector.

As February 2026 begins, U.S. stock markets have shown a strong start with major indexes like the Dow Jones and S&P 500 posting significant gains. This positive momentum sets an intriguing backdrop for investors exploring various segments of the market, including penny stocks. Although often seen as a relic from past trading eras, penny stocks—typically representing smaller or newer companies—continue to offer potential growth opportunities when backed by robust financial health. In this...